HK1011527A1 - Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases - Google Patents

Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Info

Publication number
HK1011527A1
HK1011527A1 HK98112906A HK98112906A HK1011527A1 HK 1011527 A1 HK1011527 A1 HK 1011527A1 HK 98112906 A HK98112906 A HK 98112906A HK 98112906 A HK98112906 A HK 98112906A HK 1011527 A1 HK1011527 A1 HK 1011527A1
Authority
HK
Hong Kong
Prior art keywords
associated diseases
pylori infection
terbinafine
medicament
manufacture
Prior art date
Application number
HK98112906A
Other languages
English (en)
Inventor
Ivan James Dalton Lindley
Neil Stewart Ryder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1011527A1 publication Critical patent/HK1011527A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
HK98112906A 1995-07-06 1998-12-07 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases HK1011527A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513750.1A GB9513750D0 (en) 1995-07-06 1995-07-06 Use of allylamines
PCT/EP1996/002970 WO1997002026A1 (en) 1995-07-06 1996-07-05 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Publications (1)

Publication Number Publication Date
HK1011527A1 true HK1011527A1 (en) 1999-07-16

Family

ID=10777201

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112906A HK1011527A1 (en) 1995-07-06 1998-12-07 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Country Status (27)

Country Link
US (1) US5935998A (ru)
EP (1) EP0863752B1 (ru)
JP (1) JP3680950B2 (ru)
KR (1) KR100425401B1 (ru)
CN (1) CN1204881C (ru)
AT (1) ATE232723T1 (ru)
AU (1) AU715270B2 (ru)
CA (1) CA2219678C (ru)
CY (1) CY2465B1 (ru)
CZ (1) CZ289440B6 (ru)
DE (1) DE69626301T2 (ru)
DK (1) DK0863752T3 (ru)
ES (1) ES2192608T3 (ru)
GB (1) GB9513750D0 (ru)
HK (1) HK1011527A1 (ru)
HU (1) HU224311B1 (ru)
IL (1) IL122853A (ru)
MX (1) MX9710093A (ru)
MY (1) MY132436A (ru)
NO (1) NO317496B1 (ru)
PL (1) PL187704B1 (ru)
RU (1) RU2193402C2 (ru)
SI (1) SI0863752T1 (ru)
SK (1) SK282874B6 (ru)
TW (1) TW522011B (ru)
WO (1) WO1997002026A1 (ru)
ZA (1) ZA965749B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) * 2002-02-05 2003-08-09 한솔케미언스 주식회사 (ｅ)-터비나핀 또는 이의 염산염의 제조방법
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
DE2862103D1 (en) * 1977-08-19 1982-11-18 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE3020113A1 (de) * 1979-06-08 1980-12-18 Sandoz Ag 2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
DE4317449A1 (de) * 1993-05-19 1994-11-24 Asche Ag Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

Also Published As

Publication number Publication date
PL187704B1 (pl) 2004-09-30
CZ1798A3 (cs) 1998-03-18
EP0863752B1 (en) 2003-02-19
ZA965749B (en) 1998-01-05
AU715270B2 (en) 2000-01-20
US5935998A (en) 1999-08-10
SI0863752T1 (en) 2003-06-30
SK282874B6 (sk) 2003-01-09
IL122853A0 (en) 1998-08-16
CA2219678A1 (en) 1997-01-23
MX9710093A (es) 1998-03-31
KR19990028725A (ko) 1999-04-15
CA2219678C (en) 2006-10-10
MY132436A (en) 2007-10-31
HUP9802929A3 (en) 1999-10-28
JP3680950B2 (ja) 2005-08-10
GB9513750D0 (en) 1995-09-06
DK0863752T3 (da) 2003-04-22
NO975790D0 (no) 1997-12-09
NO317496B1 (no) 2004-11-08
KR100425401B1 (ko) 2004-07-16
DE69626301D1 (de) 2003-03-27
CY2465B1 (en) 2005-06-03
CN1204881C (zh) 2005-06-08
AU6519596A (en) 1997-02-05
CN1189775A (zh) 1998-08-05
IL122853A (en) 2001-04-30
JPH11508580A (ja) 1999-07-27
ES2192608T3 (es) 2003-10-16
DE69626301T2 (de) 2003-10-16
CZ289440B6 (cs) 2002-01-16
RU2193402C2 (ru) 2002-11-27
TW522011B (en) 2003-03-01
HUP9802929A2 (hu) 1999-09-28
WO1997002026A1 (en) 1997-01-23
SK698A3 (en) 1998-05-06
HU224311B1 (hu) 2005-07-28
EP0863752A1 (en) 1998-09-16
NO975790L (no) 1997-12-09
PL323305A1 (en) 1998-03-16
ATE232723T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
DE122010000050I2 (de) Sublinguales oder bukkales arzneimittel.
AU684059B2 (en) Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes
SE9401728D0 (sv) New compounds II
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
HK1011527A1 (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
CZ176395A3 (en) The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110705